The Boston Consulting Group (BCG) is a global management consulting firm and the world’s leading advisor on business strategy. Now in our sixth decade, we continue not only to grow but also to embody the same timeless sense of purpose and the constant call for renewal that our founder Bruce Henderson instilled at our inception. Our mission is clear. We go deep to unlock insight and have the courage to act. We bring the right people together to challenge established thinking and drive transformation. We work with our clients to build the capabilities that enable organizations to achieve sustainable advantage. We are shaping the future.
The Novo Nordisk Foundation is an independent Danish foundation with corporate interests. The Foundation has two objectives:
1) to provide a stable basis for the commercial and research activities of the companies in the Novo Group (Novo Nordisk A/S and Novozymes A/S)
2) to support scientific, humanitarian and social causes.
The objective of the Otto Moensted Foundation is to contribute to the development of Danish trade and industry.
According to the original deed of the foundation from 1934, the distributions from the Foundation are intended for:
1. Supporting the education of talented young businessmen and engineering students or graduates with no or limited private means.
2. educating teachers at business schools, the Technical University of Denmark (DTU) and possibly the technical colleges in Denmark.
3. Promoting and developing plans and undertakings within trade and industry which the Board of the foundation deems to have the potential for promoting Denmark´s commercial and corporate sectors or otherwise being honourable for Denmark.
Novartis is one of the world's leading life science companies. We work to develop the most groundbreaking treatments for people with unmet medical needs.
In Denmark, we collaborate with skilled healthcare professionals in hospitals and medical centers. In addition, we are one of the life science companies with the most clinical trials taking place in the country. We also work with patient associations and all other key players in the healthcare system, who share our ambition to eliminate serious diseases.
Novo Nordisk, Regulatory Affairs secure the approval of new multi-billion dollar products and drug indications, making it possible for the company to bring innovative products to patients. The department stand at the centre of project planning and execution from the earliest stages of drug development all the way through life cycle management. A close collaboration with scientists to ensure new ideas will turn into successful products, thus a large part of Regulatory Affairs is based on the ability to understand the science behind.
The Regulatory Affairs graduate programme has been designed to develop top talents into becoming future leaders within this area. The Graduate Program is a two-year program consisting of three department rotations in which one of these will take place in one of the global affiliates. The Programme is open to applicants from all over the world who have recently acquired a degree from the life sciences such as pharmacy, chemical engineering, biology, biotechnology biomedicine or a related field.
I Tuborgfondet tror vi på fællesskabet. Vi støtter iværksætterne, ildsjælene og forandringsagenterne. Dem, der bringer flere ind i fællesskabet, udvider potentialet og baner vejen for, at flere unge opfylder deres drømme, dannes til arbejdslivet og får indflydelse i samfundet.
Medicon Valley Alliance's (MVA) vision is to be a well-known and respected member-driven contributor to the realization and positioning of Medicon Valley as the most competitive and vital life science cluster in northern Europe. MVA is committed to realising the potential of Medicon Valley by facilitating networking and knowledge sharing, collaboration, analysing challenges and potentials, and mobilising support from key opinion leaders.
Horten is a full-service law firm with more than 60 years’ experience and 320 employees, which is specialised within sectors characterised by strict regulation or where technological development and innovative approaches are fundamental – such as energy and supply, Life Science and Healthcare, IT, technology and media as well as the public sector.
We use our special expertise within regulated areas proactively to solve complex problems and think innovatively, be it new energy forms, advanced technology or cooperation between public and private parties.
HØIBERG is a full-service patent law firm located in Denmark, which is providing services within the fields of Intellectual Property Rights (IPR), including patents, designs, innovation management, technology transfer and business development. HØIBERG provides expert IPR knowledge in the fields ranging from biotech, medtech, nanotech, chemistry and cleantech to software, electronics and mechanics.
The Danish Society of Engineers, IDA – a modern professional association for technical, IT and natural sciences professionals.
IDA has more than 125.000 members and represents the interests of employees, managers and self-employed within the fields of pay and employment, the labour market, industrial policy, skills, careers and training, the working environment, technology and research.
IDA’s vision is to help technical knowledge workers set the agenda via competence development, network establishment, and political influence.
IDA’s goal is to be an influential, high profile society. Several politically appointed committees ensure that the views and objectives of our society become known and are made visible in areas ranging from education policy, equal opportunity, industrial and labour market policies, work environment and research and technology.
BII offers entrepreneurially-minded researchers or anyone with a research-based idea help to bring interdisciplinary ideas to life and research to market. We offer state-of-the-art facilities and various funding opportunities, as well as partnerships and programs with technical, scientific and commercial experts.
Our main focus is health tech, bio-industrials and therapeutics. We envision that strong collaborations, a passion for science, and an open mind will foster research-based innovation and viable start-ups. BII does not work for profit but for the benefit of human welfare and society around the globe.
BII is a Novo Nordisk Foundation initiative. In the first three years of operation, until the end of 2020, BII has been granted DKK 392 million. After this establishment phase has been evaluated, the Novo Nordisk Foundation’s Board of Directors will decide whether to establish BII as an independent foundation and grant funding for the next seven years of operation.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes Ostomy Care, Continence Care, Wound & Skin Care and Interventional Urology. We operate globally, and our organisation is about 11,000 people strong
KMP+ House of Mentoring has since 2000 designed and delivered state-of-the-art mentoring programmes based on in-depth research and good practice. Together with the client, we ensure that development activities are relevant, meaningful to the individual, and clearly connect to strategic objectives, thus increasing the organisation’s ability to deliver results.
Since 2017, KMP+ House of Mentoring has facilitated Synapse’s kick-off event by using the engaging and innovative concept Mentor+Game™ to train the mentors and mentees in the skills of modern mentoring. The kick-off event enhances the learning experience of mentors and mentees and ensure that all mentors and mentees within the Synapse Mentoring Programme are provided a common language and tools for their collaboration.